Physician profile
Ashley E Diehl
NPI 1316230865
$529.49
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.24 · 2022: $15.22 · 2023: $163 · 2024: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $130.95 | 2024 | Qelbree |
| Merck Sharp & Dohme LLC | $65.78 | 2024 | Gardasil 9, Gardasil, Vaxelis |
| Pfizer INC. | $50.03 | 2023-2024 | |
| Dexcom, INC. | $44.78 | 2023-2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $34.23 | 2023-2024 | Jardiance, Zepbound |
| Phadia US INC. | $31.86 | 2023-2024 | Immunocap |
| Astrazeneca Pharmaceuticals LP | $28.79 | 2023-2024 | Farxiga |
| Exact Sciences Corporation | $27.10 | 2023 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $21.07 | 2023 | Gvoke Hypopen |
| Ironshore Pharmaceuticals INC. | $18.69 | 2024 | |
| Novo Nordisk INC | $17.76 | 2023 | |
| Abbvie INC. | $16.75 | 2023 | Vraylar |
| Takeda Pharmaceuticals U.S.A., INC. | $15.22 | 2022 | |
| Owp Pharmaceuticals, INC. | $14.24 | 2024 | Subvenite |
| Shire North American Group INC | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Diehl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.